U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07444502) titled 'Safety Monitoring of Boostagen(R) Vaccine in Thailand' on Feb. 26.
Brief Summary: This study is designed to monitor the safety of Boostagen(R) after it has been approved for use in Thailand. The study follows people who receive the vaccine in routine medical practice to identify and record any side effects.
Doctors, nurses, and other healthcare professionals from hospitals and clinics in central, eastern, southern, and northern Thailand take part in the study. They report any health problems that occur after vaccination using standard reporting forms.
The information collected helps researchers understand how safe the vaccine is w...